Researcher
Herlinde Dumez
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From1 Oct 2005 → Today
Publications
41 - 50 of 64
- Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases(2012)
Authors: Benoit Beuselinck, Herlinde Dumez, Aljosja Rogiers, Ludo Willems, Joost Berkers, Hendrik Van Poppel, Evelyne Lerut, Robert Paridaens, Patrick Schöffski
Pages: 1665 - 1671 - Using Pharmacokinetic and Pharmacodynamic Data in Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788(2012)
Authors: Patrick Schöffski, Herlinde Dumez, Allan Van Oosterom
Pages: 6364 - 6372 - THE VALUE OF DIFFUSION-WEIGHTED IMAGING IN EWING'S SARCOMA AND OSTEOSARCOMA IN CHILDREN AND YOUNG ADULTS: A RELIABLE PARAMETER FOR THERAPY ASSESSMENT? PRELIMINARY RESULTS(2012)
Authors: Steven Pans, Stefan Ghysels, Frederik De Keyzer, Raf Sciot, Ignace Samson, Friedl Sinnaeve, Herlinde Dumez, Marleen Renard, Anne Uyttebroeck
Pages: 1049 - 1049 - Administration of 24-h Intravenous Infusions of Trabectedin in Ambulatory Patients with Mesenchymal Tumors via Disposable Elastomeric Pumps: An Effective and Patient-Friendly Palliative Treatment Option(2012)
Authors: Patrick Schöffski, Ivo De Wever, Herlinde Dumez, Paul Clement, Hans Wildiers, Marguerite Stas
Pages: 14 - 17 - Administration of 24-h Intravenous Infusions of Trabectedin in Ambulatory Patients with Mesenchymal Tumors via Disposable Elastomeric Pumps: An Effective and Patient-Friendly Palliative Treatment Option(2012)
Authors: Patrick Schöffski, Linda Cerbone, Pascal Wolter, Ivo De Wever, Ignace Samson, Herlinde Dumez, Paul Clement, Hans Wildiers, Marguerite Stas
Pages: 14 - 17 - A phase I, dose-escalation study of the novel Polo-like kinase inhibitor volasertib (BI 6727) in patients with advanced solid tumours(2012)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 179 - 186 - Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies(2011)
Authors: Patrick Schöffski, Herlinde Dumez
Pages: 1397 - 1403 - Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes(2011)
Authors: Patrick Schöffski, Raf Sciot, Herlinde Dumez
Pages: 1045 - 1052 - Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours(2011)
Authors: Herlinde Dumez, Benoit Beuselinck, Patrick Schöffski
Pages: 1328 - 1335 - A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974)(2011)
Authors: Herlinde Dumez
Pages: 1054 - 61